Consent forms, intake packs and clinic documentation built specifically for peptide practices — with honest, up-to-date regulatory language (FDA 503A, compounding status) that generic templates skip.
The complete documentation system for peptide practices: five substance-specific informed consents (BPC-157, CJC-1295/Ipamorelin, Sermorelin, NAD+, Glutathione), peptide-specific intake, good-faith exam, chart notes, telehealth consent, full HIPAA pack, patient bill of rights and an adverse-event protocol..
Substance-specific informed consent for NAD+ injections and infusions — including rate-dependent infusion reactions and honest compounded-medication language..
An honest, thorough BPC-157 consent: investigational status, FDA compounding category history, unknown long-term effects — the disclosure serious clinics actually need..
Three complete growth-hormone-secretagogue consents in one pack — each with its own current regulatory story, from Sermorelin's discontinued-approval history to CJC-1295's Category 2 saga..
Standalone Sermorelin informed consent with accurate regulatory framing (former FDA-approved drug, compounded today) and GH-axis risk language..
Blend-specific informed consent for the most-prescribed GH peptide combination, current to the 2023-24 FDA compounding review..
IV/IM glutathione consent with sulfite-sensitivity cautions and the 2019 FDA compounding alert reflected — not a generic vitamin form with the name swapped..
Join the launch list for 25% off your first order.